Sun Pharma shelling out $485M to settle US antitrust case against generics giant

Sun Pharma has agreed to a big payout to settle claims of misconduct leveled against its Ranbaxy generics unit.

Just ahead of a trial over long-simmering allegations that Ranbaxy had schemed to muscle ahead of rivals and hit the market with 3 exclusive knockoffs of some of the biggest medicines...

Click to view original post